Notice of Change in Prenatal/Perinatal Screening for CT/GC During COVID Pandemic

Until further notice, Nova Scotia is changing to urine testing for prenatal/perinatal Chlamydia trachomatis (CT) and Neisseriae gonorrhoeae (GC). The reason for the switch is that Aptima swabs are required for COVID-19 testing. The sensitivity of the two testing methods is equivalent so case detection should not change.

  • Collect sample in a sterile urine container. Ensure container has at least 20 milliliters of urine.
  • Complete the standard outpatient lab requisition.

Please return any swabs in your offices/clinics to the closet hospital laboratory.

If you have any questions, please contact the microbiologist on call.